0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Embolization Particle Market Research Report 2023
Published Date: August 2023
|
Report Code: QYRE-Auto-33P8693
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Embolization Particle Market Outlook 2022
BUY CHAPTERS

Global Embolization Particle Market Research Report 2023

Code: QYRE-Auto-33P8693
Report
August 2023
Pages:90
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Embolization Particle Market Size

The global Embolization Particle market was valued at US$ 2012.7 million in 2022 and is anticipated to reach US$ 5248.9 million by 2029, witnessing a CAGR of 14.5% during the forecast period 2023-2029.

Embolization Particle Market

Embolization Particle Market

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Embolization Particle Market Report

Report Metric Details
Report Name Embolization Particle Market
Accounted market size in 2022 US$ 2012.7 million
Forecasted market size in 2029 US$ 5248.9 million
CAGR 14.5%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Microspheres
  • Particles (e.g. PVA Particles, Gelfoam Particles)
  • Drug-eluting Beads (DEBs)
  • Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
  • COVID-19 and Russia-Ukraine War Influence Analysis
  • The readers in the section will understand how the Embolization Particle market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
  • Reasons to Buy This Report
  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Embolization Particle industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Analysis of sales channel, distributors and customers
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
  • Chapter 11: The main points and conclusions of the report.

FAQ for this report

How fast is Embolization Particle Market market growing?

Ans: The Embolization Particle Market market witnessing a CAGR of 14.5% during the forecast period 2023-2029.

What is the Embolization Particle Market market size in 2029?

Ans: The global Embolization Particle market was valued at US$ 2012.7 million in 2022 and is anticipated to reach US$ 5248.9 million by 2029, witnessing a CAGR of 14.5% during the forecast period 2023-2029.

1 Embolization Particle Market Overview
1.1 Product Overview and Scope of Embolization Particle
1.2 Embolization Particle Segment by Type
1.2.1 Global Embolization Particle Market Value Comparison by Type (2023-2029)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Segment by Application
1.3.1 Global Embolization Particle Market Value by Application: (2023-2029)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global Embolization Particle Market Size Estimates and Forecasts
1.4.1 Global Embolization Particle Revenue 2018-2029
1.4.2 Global Embolization Particle Sales 2018-2029
1.4.3 Global Embolization Particle Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Embolization Particle Market Competition by Manufacturers
2.1 Global Embolization Particle Sales Market Share by Manufacturers (2018-2023)
2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Embolization Particle Average Price by Manufacturers (2018-2023)
2.4 Global Embolization Particle Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Embolization Particle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolization Particle, Product Type & Application
2.7 Embolization Particle Market Competitive Situation and Trends
2.7.1 Embolization Particle Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Embolization Particle Players Market Share by Revenue
2.7.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Embolization Particle Retrospective Market Scenario by Region
3.1 Global Embolization Particle Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Embolization Particle Global Embolization Particle Sales by Region: 2018-2029
3.2.1 Global Embolization Particle Sales by Region: 2018-2023
3.2.2 Global Embolization Particle Sales by Region: 2024-2029
3.3 Global Embolization Particle Global Embolization Particle Revenue by Region: 2018-2029
3.3.1 Global Embolization Particle Revenue by Region: 2018-2023
3.3.2 Global Embolization Particle Revenue by Region: 2024-2029
3.4 North America Embolization Particle Market Facts & Figures by Country
3.4.1 North America Embolization Particle Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Embolization Particle Sales by Country (2018-2029)
3.4.3 North America Embolization Particle Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolization Particle Market Facts & Figures by Country
3.5.1 Europe Embolization Particle Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Embolization Particle Sales by Country (2018-2029)
3.5.3 Europe Embolization Particle Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolization Particle Market Facts & Figures by Country
3.6.1 Asia Pacific Embolization Particle Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Embolization Particle Sales by Country (2018-2029)
3.6.3 Asia Pacific Embolization Particle Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolization Particle Market Facts & Figures by Country
3.7.1 Latin America Embolization Particle Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Embolization Particle Sales by Country (2018-2029)
3.7.3 Latin America Embolization Particle Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Embolization Particle Sales by Country (2018-2029)
3.8.3 Middle East and Africa Embolization Particle Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolization Particle Sales by Type (2018-2029)
4.1.1 Global Embolization Particle Sales by Type (2018-2023)
4.1.2 Global Embolization Particle Sales by Type (2024-2029)
4.1.3 Global Embolization Particle Sales Market Share by Type (2018-2029)
4.2 Global Embolization Particle Revenue by Type (2018-2029)
4.2.1 Global Embolization Particle Revenue by Type (2018-2023)
4.2.2 Global Embolization Particle Revenue by Type (2024-2029)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2018-2029)
4.3 Global Embolization Particle Price by Type (2018-2029)
5 Segment by Application
5.1 Global Embolization Particle Sales by Application (2018-2029)
5.1.1 Global Embolization Particle Sales by Application (2018-2023)
5.1.2 Global Embolization Particle Sales by Application (2024-2029)
5.1.3 Global Embolization Particle Sales Market Share by Application (2018-2029)
5.2 Global Embolization Particle Revenue by Application (2018-2029)
5.2.1 Global Embolization Particle Revenue by Application (2018-2023)
5.2.2 Global Embolization Particle Revenue by Application (2024-2029)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2018-2029)
5.3 Global Embolization Particle Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Corporation Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sirtex Medical Embolization Particle Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Corporation Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merit Medical Embolization Particle Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Corporation Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cook Medical Embolization Particle Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Corporation Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BTG Medical Embolization Particle Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Corporation Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Corporation Embolization Particle Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.6.1 HENGRUI Medical Corporation Information
6.6.2 HENGRUI Medical Description and Business Overview
6.6.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HENGRUI Medical Embolization Particle Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials B.V.
6.8.1 INterface BIOmaterials B.V. Corporation Information
6.8.2 INterface BIOmaterials B.V. Description and Business Overview
6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
6.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Corporation Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Alicon Embolization Particle Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolization Particle Industry Chain Analysis
7.2 Embolization Particle Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolization Particle Production Mode & Process
7.4 Embolization Particle Sales and Marketing
7.4.1 Embolization Particle Sales Channels
7.4.2 Embolization Particle Distributors
7.5 Embolization Particle Customers
8 Embolization Particle Market Dynamics
8.1 Embolization Particle Industry Trends
8.2 Embolization Particle Market Drivers
8.3 Embolization Particle Market Challenges
8.4 Embolization Particle Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Embolization Particle Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Embolization Particle Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Embolization Particle Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Embolization Particle Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Embolization Particle Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Embolization Particle Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Embolization Particle Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Embolization Particle Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Embolization Particle, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Embolization Particle, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Embolization Particle, Product Type & Application
    Table 12. Global Key Manufacturers of Embolization Particle, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Embolization Particle Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Embolization Particle Sales by Region (2018-2023) & (K Units)
    Table 18. Global Embolization Particle Sales Market Share by Region (2018-2023)
    Table 19. Global Embolization Particle Sales by Region (2024-2029) & (K Units)
    Table 20. Global Embolization Particle Sales Market Share by Region (2024-2029)
    Table 21. Global Embolization Particle Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Embolization Particle Revenue Market Share by Region (2018-2023)
    Table 23. Global Embolization Particle Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Embolization Particle Revenue Market Share by Region (2024-2029)
    Table 25. North America Embolization Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Embolization Particle Sales by Country (2018-2023) & (K Units)
    Table 27. North America Embolization Particle Sales by Country (2024-2029) & (K Units)
    Table 28. North America Embolization Particle Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Embolization Particle Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Embolization Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Embolization Particle Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Embolization Particle Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Embolization Particle Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Embolization Particle Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Embolization Particle Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Embolization Particle Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Embolization Particle Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Embolization Particle Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Embolization Particle Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Embolization Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Embolization Particle Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Embolization Particle Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Embolization Particle Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Embolization Particle Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Embolization Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Embolization Particle Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Embolization Particle Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Embolization Particle Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Embolization Particle Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Embolization Particle Sales (K Units) by Type (2018-2023)
    Table 51. Global Embolization Particle Sales (K Units) by Type (2024-2029)
    Table 52. Global Embolization Particle Sales Market Share by Type (2018-2023)
    Table 53. Global Embolization Particle Sales Market Share by Type (2024-2029)
    Table 54. Global Embolization Particle Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Embolization Particle Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Embolization Particle Revenue Market Share by Type (2018-2023)
    Table 57. Global Embolization Particle Revenue Market Share by Type (2024-2029)
    Table 58. Global Embolization Particle Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Embolization Particle Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Embolization Particle Sales (K Units) by Application (2018-2023)
    Table 61. Global Embolization Particle Sales (K Units) by Application (2024-2029)
    Table 62. Global Embolization Particle Sales Market Share by Application (2018-2023)
    Table 63. Global Embolization Particle Sales Market Share by Application (2024-2029)
    Table 64. Global Embolization Particle Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Embolization Particle Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Embolization Particle Revenue Market Share by Application (2018-2023)
    Table 67. Global Embolization Particle Revenue Market Share by Application (2024-2029)
    Table 68. Global Embolization Particle Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Embolization Particle Price (USD/Unit) by Application (2024-2029)
    Table 70. Sirtex Medical Corporation Information
    Table 71. Sirtex Medical Description and Business Overview
    Table 72. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Sirtex Medical Embolization Particle Product
    Table 74. Sirtex Medical Recent Developments/Updates
    Table 75. Merit Medical Corporation Information
    Table 76. Merit Medical Description and Business Overview
    Table 77. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Merit Medical Embolization Particle Product
    Table 79. Merit Medical Recent Developments/Updates
    Table 80. Cook Medical Corporation Information
    Table 81. Cook Medical Description and Business Overview
    Table 82. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Cook Medical Embolization Particle Product
    Table 84. Cook Medical Recent Developments/Updates
    Table 85. BTG Medical Corporation Information
    Table 86. BTG Medical Description and Business Overview
    Table 87. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. BTG Medical Embolization Particle Product
    Table 89. BTG Medical Recent Developments/Updates
    Table 90. Boston Scientific Corporation Corporation Information
    Table 91. Boston Scientific Corporation Description and Business Overview
    Table 92. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Boston Scientific Corporation Embolization Particle Product
    Table 94. Boston Scientific Corporation Recent Developments/Updates
    Table 95. Terumo Corporation Corporation Information
    Table 96. Terumo Corporation Description and Business Overview
    Table 97. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Terumo Corporation Embolization Particle Product
    Table 99. Terumo Corporation Recent Developments/Updates
    Table 100. HENGRUI Medical Corporation Information
    Table 101. HENGRUI Medical Description and Business Overview
    Table 102. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. HENGRUI Medical Embolization Particle Product
    Table 104. HENGRUI Medical Recent Developments/Updates
    Table 105. INterface BIOmaterials B.V. Corporation Information
    Table 106. INterface BIOmaterials B.V. Description and Business Overview
    Table 107. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. INterface BIOmaterials B.V. Embolization Particle Product
    Table 109. INterface BIOmaterials B.V. Recent Developments/Updates
    Table 110. Alicon Corporation Information
    Table 111. Alicon Description and Business Overview
    Table 112. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Alicon Embolization Particle Product
    Table 114. Alicon Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Embolization Particle Distributors List
    Table 118. Embolization Particle Customers List
    Table 119. Embolization Particle Market Trends
    Table 120. Embolization Particle Market Drivers
    Table 121. Embolization Particle Market Challenges
    Table 122. Embolization Particle Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Embolization Particle
    Figure 2. Global Embolization Particle Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Embolization Particle Market Share by Type in 2022 & 2029
    Figure 4. Microspheres Product Picture
    Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
    Figure 6. Drug-eluting Beads (DEBs) Product Picture
    Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
    Figure 8. Global Embolization Particle Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Embolization Particle Market Share by Application in 2022 & 2029
    Figure 10. Uterine Fibroid Embolization
    Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Figure 12. Liver Tumor Embolization
    Figure 13. Trauma Embolization
    Figure 14. Others
    Figure 15. Global Embolization Particle Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Embolization Particle Market Size (2018-2029) & (US$ Million)
    Figure 17. Global Embolization Particle Sales (2018-2029) & (K Units)
    Figure 18. Global Embolization Particle Average Price (USD/Unit) & (2018-2029)
    Figure 19. Embolization Particle Report Years Considered
    Figure 20. Embolization Particle Sales Share by Manufacturers in 2022
    Figure 21. Global Embolization Particle Revenue Share by Manufacturers in 2022
    Figure 22. The Global 5 and 10 Largest Embolization Particle Players: Market Share by Revenue in 2022
    Figure 23. Embolization Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 24. Global Embolization Particle Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 25. North America Embolization Particle Sales Market Share by Country (2018-2029)
    Figure 26. North America Embolization Particle Revenue Market Share by Country (2018-2029)
    Figure 27. U.S. Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Canada Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Europe Embolization Particle Sales Market Share by Country (2018-2029)
    Figure 30. Europe Embolization Particle Revenue Market Share by Country (2018-2029)
    Figure 31. Germany Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. France Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. U.K. Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Italy Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Russia Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Asia Pacific Embolization Particle Sales Market Share by Region (2018-2029)
    Figure 37. Asia Pacific Embolization Particle Revenue Market Share by Region (2018-2029)
    Figure 38. China Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Japan Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. South Korea Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. India Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Australia Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Taiwan Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Indonesia Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Thailand Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Malaysia Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Philippines Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Latin America Embolization Particle Sales Market Share by Country (2018-2029)
    Figure 49. Latin America Embolization Particle Revenue Market Share by Country (2018-2029)
    Figure 50. Mexico Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Argentina Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Embolization Particle Sales Market Share by Country (2018-2029)
    Figure 54. Middle East & Africa Embolization Particle Revenue Market Share by Country (2018-2029)
    Figure 55. Turkey Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. U.A.E Embolization Particle Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Global Sales Market Share of Embolization Particle by Type (2018-2029)
    Figure 59. Global Revenue Market Share of Embolization Particle by Type (2018-2029)
    Figure 60. Global Embolization Particle Price (USD/Unit) by Type (2018-2029)
    Figure 61. Global Sales Market Share of Embolization Particle by Application (2018-2029)
    Figure 62. Global Revenue Market Share of Embolization Particle by Application (2018-2029)
    Figure 63. Global Embolization Particle Price (USD/Unit) by Application (2018-2029)
    Figure 64. Embolization Particle Value Chain
    Figure 65. Embolization Particle Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Transcatheter Aortic Valve Replacement (TAVR) Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-15W12910
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Dynamic Blood Pressure Monitor Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-18Q9277
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Diagnostic Electrocardiograph (ECG) Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-3U478
Fri Sep 22 00:00:00 UTC 2023

Add to Cart

Global Valsartan and Amlodipine Tablets Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-6C15559
Fri Sep 22 00:00:00 UTC 2023

Add to Cart